Dargantes, Bonifacio T.

HRN: 24-97-19  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/05/2024
05/12/2024
IVT
2.25g
Q6
Infected Wound, Right Foot
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Disseminated Systemic Infection    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: